Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Naproxcinod

Generic Name: Naproxcinod

Drug Type: Small Molecule

Chemical Formula: C_₁₈H_₂₁NO_₆

CAS Number: 163133-43-5

Unique Ingredient Identifier: V24GR4LI3I

Overview

No overview information available.

Background

No background information available.

Indication

Investigated for use/treatment in pain (acute or chronic), inflammatory disorders (unspecified), osteoarthritis, and arthritis and arthritic pain.

Associated Conditions

No associated conditions information available.

Clinical Trials

Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male

Phase 1

Completed

Posted: 2011/07/28

Sponsor:NicOx

ID:NCT01404598

Effect of Repeated Dosing of Naproxcinod on Renal Hemodynamic and on Sodium Balance in Healthy Volunteers Before and After a Single Dose of Furosemide

Phase 1

Completed

Posted: 2009/05/28

Sponsor:NicOx

ID:NCT00909519

A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function

Phase 1

Completed

Posted: 2008/05/08

Sponsor:NicOx

ID:NCT00674856

To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension

Phase 1

Completed

Posted: 2008/04/21

Sponsor:NicOx

ID:NCT00662896

A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure

Phase 1

Completed

Posted: 2008/04/21

Sponsor:NicOx

ID:NCT00662610

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy